Your browser doesn't support javascript.
loading
Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins.
Al-Sallami, Hesham S; Barras, Michael A; Green, Bruce; Duffull, Stephen B.
Affiliation
  • Al-Sallami HS; School of Pharmacy, University of Otago, Dunedin, New Zealand. hesham.al-sallami@otago.ac.nz
Clin Pharmacokinet ; 49(9): 567-71, 2010 Sep.
Article in En | MEDLINE | ID: mdl-20690780
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Monitoring / Enoxaparin / Factor Xa Inhibitors / Anticoagulants Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacokinet Year: 2010 Document type: Article Affiliation country: New Zealand Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Monitoring / Enoxaparin / Factor Xa Inhibitors / Anticoagulants Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacokinet Year: 2010 Document type: Article Affiliation country: New Zealand Country of publication: Switzerland